Abstract
Background & Aim: Low back pain is broadly documented as one of the most widespread pathologies in the advanced domain. Although the reasons of low back pain are uncountable, it has been meaningfully related to intervertebral disc degeneration. Present therapies for intervertebral disc (IVD) degeneration such as physical therapy and spinal fusion reduce symptoms' severity, but do not treat the source of degeneration. The use of tissue engineering to treat disc degeneration offers a chance to control the pathological course. New methods are presently being examined and have exposed mixed results. One major way of study has been stem cell injections. We go on to define the course of stem cell-mediated modalities in treatment of degenerative lumbar disc herniation Methods & Materials: Literature search was performed in electronic databases PUBMED and EMBASE by means of MeSH terminologies (nucleus pulposus, therapeutics, annulus fibrosus, intervertebral disc) and keywords (degenerative disc disease, stem cells, therapy). Results: The intervertebral disc organization, developing treatments, mesenchymal stem cells (MSCs), embryonic stem cells, and practice in disc degeneration were some sections found in analysis for study review design. Conclusion: MSCs have revealed potentials in small animal models. Nonetheless, consequences in greater vertebrates have been varied.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
